Back to Search
Start Over
Difuran-substituted quinoxalines as a novel class of PI3Kα H1047R mutant inhibitors: Synthesis, biological evaluation and structure-activity relationship.
- Source :
-
European journal of medicinal chemistry [Eur J Med Chem] 2018 Sep 05; Vol. 157, pp. 37-49. Date of Electronic Publication: 2018 Jul 29. - Publication Year :
- 2018
-
Abstract
- Phosphatidylinositol 3-kinase α (PI3Kα) is the most frequently mutated kinase in human cancers, making it an attractive therapeutic target for cancer treatment. We identified a structurally novel PI3Kα H1047R mutant inhibitor Hit-01 (EC <subscript>50</subscript> = 76.0 μM) through a high-throughput screening campaign. Chemical optimizations enabled us to discover compound 7b, which strongly inhibited PI3Kα H1047R mutant with an EC <subscript>50</subscript> value of 0.137 μM, over 500-fold more potent than Hit-01. Western blotting analysis suggested that 7b could decrease the phosphorylation level of p-AKT, another proof that 7b inhibited PI3Kα H1047R function. Cell viability assay revealed that 7b inhibited HCT116 cancer cell growth with an IC <subscript>50</subscript> value of 11.23 μM. In addition, 7b was found to arrest cell cycle at G1 phase and induce cell apoptosis via up-regulation of caspase-3, caspase-8 and caspase-9 protein expressions. Collectively, all these data demonstrated that 7b could be a promising lead for the development of structurally novel PI3Kα inhibitors.<br /> (Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
- Subjects :
- Antineoplastic Agents chemical synthesis
Antineoplastic Agents chemistry
Apoptosis drug effects
Cell Cycle Checkpoints drug effects
Cell Proliferation drug effects
Cell Survival drug effects
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Furans chemistry
HCT116 Cells
Humans
MCF-7 Cells
Molecular Docking Simulation
Molecular Structure
Mutation
Phosphatidylinositol 3-Kinases genetics
Phosphatidylinositol 3-Kinases metabolism
Quinoxalines chemical synthesis
Quinoxalines chemistry
Structure-Activity Relationship
Antineoplastic Agents pharmacology
Furans pharmacology
Phosphoinositide-3 Kinase Inhibitors
Quinoxalines pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1768-3254
- Volume :
- 157
- Database :
- MEDLINE
- Journal :
- European journal of medicinal chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 30071408
- Full Text :
- https://doi.org/10.1016/j.ejmech.2018.07.061